Advisory Panel of Experts Endorses F.D.A. Approval of New Alzheimer's DrugThe modest benefits of the treatment, donanemab, made by Eli Lilly, outweigh the risks, the panel concluded unanimously.
Source: Advisory Panel of Experts Endorses F.D.A. Approval of New Alzheimer's Drug (https://www.nytimes.com/2024/06/10/health/alzheimers-treatment-donanemab.html)